Skip to content

Study on the efficacy of OFA in lower abdominal surgery with B-ultrasound-guided QLB in supine position

Study on the efficacy of OFA in lower abdominal surgery with B-ultrasound-guided QLB in supine position

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072842
Enrollment
Unknown
Registered
2023-06-26
Start date
2021-10-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasound-guided QLB+ TAPfor OFA in lower abdominal surgery

Interventions

Experimental group:Bilateral ultrasound guided QLB +TAP block
Control group:Traditional opioid anesthesia with sufentanil + remifentanil was used

Sponsors

Hainan Wanning People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-65 years; ASA Grade I-III patients (2) had normal liver and kidney function and were scheduled to be hospitalized for =48h after surgery; (3) The lower abdomen or pelvis, open or endoscopic surgery was performed. (4) There was no history of allergy to the drugs used in this study.

Exclusion criteria

Exclusion criteria: (1) Refuse to sign informed consent or participate in the study. (2) Have severe circulatory insufficiency, arrhythmia (especially bradycardia), hypovolemia, shock, coronary instability, autonomic neuropathy with orthostatic hypotension. (3) Mental illness and chronic pain that may confuse analgesia. (4) inability to communicate or difficulty communicating. (5) have blood pressure Or severe risk of elevated intracranial pressure (6) poorly controlled or untreated hypertension > 180/100 MMHG (7) untreated or undertreated hyperthyroidism.

Design outcomes

Primary

MeasureTime frame
Bispectral index,BIS;Blood pressure;Heart rate;Finger oxygen saturation;electrocardiogram;

Secondary

MeasureTime frame
Propofol dosage;Rocuronium bromide dosage;Dexmedetomidine dosage;

Countries

China

Contacts

Public ContactDAI Jingwei

Hainan Wanning People's Hospital

daijingwei2021@163.com+86 158 0892 8236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026